The cohort covers more than 20 years of data collection and originally included approximately 5,000 patients according to the Amsterdam Cohort Hub overview. Measurements include neurological tests, cognition tests, eye-movement tests, MRI scans, blood biomarkers and imaging of brain networks to study progression and underlying mechanisms of MS.
Website: https://www.amsterdamumc.org/en/departments/ms-center-amsterdam-1.htm